These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 608855)

  • 41. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD.
    Douma CE; de Waart DR; Zemel D; Struijk DG; Krediet RT
    Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peritoneal clearances with different dialysis regimens in children undergoing continuous cycling peritoneal dialysis.
    Leichter HE; Salusky IB; von Lilien T; Laidlaw S; Alliapoulos JC; Hall TL; Fine RN
    Nephrol Dial Transplant; 1989; 4(10):893-9. PubMed ID: 2515495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peritoneal phosphate removal varies by peritoneal dialysis regimen: an underestimated parameter of phosphate control.
    Botelho C; Rodrigues A; Oliveira JC; Cabrita A
    J Nephrol; 2013; 26(1):183-90. PubMed ID: 22460184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of ultrafiltration on peritoneal dialysis drug clearances.
    Lau AH; Chow-Tung E; Assadi FK; Fornell L; John E
    Pharmacology; 1985; 31(5):284-8. PubMed ID: 4070353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of vasodilators on peritoneal solute and fluid transport in rat peritoneal dialysis.
    Kumano K; Go M; Ning H; Sakai T
    Adv Perit Dial; 1996; 12():27-32. PubMed ID: 8865867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Measuring the thickness of the peritoneum as a dialysis membrane using various osmolar concentrations of dialysis fluid].
    Korten G
    Z Urol Nephrol; 1990 Aug; 83(8):459-63. PubMed ID: 2238886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tidal peritoneal dialysis for home-treated patients: should it be preferred?
    Vychytil A; Lilaj T; Schneider B; Hörl WH; Haag-Weber M
    Am J Kidney Dis; 1999 Feb; 33(2):334-43. PubMed ID: 10023647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tidal peritoneal dialysis: comparison of different tidal regimens and automated peritoneal dialysis.
    Juergensen PH; Murphy AL; Pherson KA; Kliger AS; Finkelstein FO
    Kidney Int; 2000 Jun; 57(6):2603-7. PubMed ID: 10844630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Practical guidelines for automated peritoneal dialysis.
    Sritippayawan S; Nilwarangkur S; Aiyasanon N; Jattanawanich P; Vasuvattakul S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S167-74. PubMed ID: 22043586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. V. Usefulness of selected parameters of peritoneal transfer for evaluating the effectiveness of intermittent peritoneal dialysis].
    Grzegorzewska A
    Przegl Lek; 1989; 46(5):440-7. PubMed ID: 2772244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of exchange volume and dialysate flow rate on solute clearance in peritoneal dialysis.
    Robson M; Oreopoulos DG; Izatt S; Ogilvie R; Rapoport A; deVeber GA
    Kidney Int; 1978 Nov; 14(5):486-90. PubMed ID: 108449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peritoneal clearances with three types of commerically available peritoneal dialysis solutions. Effects of pH adjustment and intraperitoneal nitroprusside.
    Nolph KD; Rubin J; Wiegman DL; Harris PD; Miller FN
    Nephron; 1979; 24(1):34-40. PubMed ID: 40148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contrasting effects of amphotericin B and the solvent sodium desoxycholate on peritoneal transport.
    Maher JF; Hirszel P; Chakrabarti E; Bennett RR
    Nephron; 1986; 43(1):38-42. PubMed ID: 3703064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of peritoneal dialysis: the PD Plus concept.
    Diaz-Buxo JA
    Am J Kidney Dis; 1996 Jan; 27(1):92-8. PubMed ID: 8546143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of intraperitoneal vancomycin on peritoneal dialysis efficiency. A clinical study.
    Janicka L; Ksiazek A; Solski J; Janicki K
    Int Urol Nephrol; 1997; 29(3):385-9. PubMed ID: 9285315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood flow limitation in vivo of small solute transfer during peritoneal dialysis in rats.
    Rosengren BI; Rippe B
    J Am Soc Nephrol; 2003 Jun; 14(6):1599-604. PubMed ID: 12761261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis.
    Nolph KD; Miller FN; Pyle WK; Popovich RP; Sorkin MI
    Kidney Int; 1981 Nov; 20(5):543-8. PubMed ID: 7343705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Augmenting solute clearance in peritoneal dialysis.
    Krediet RT; Douma CE; van Olden RW; Ho-dac-Pannekeet MM; Struijk DG
    Kidney Int; 1998 Dec; 54(6):2218-25. PubMed ID: 9853288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.